Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - luis+martinez-sobrido
6
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Human Monoclonal Antibodies for Prevention and Treatment of Influenza Virus Infections
Background Seasonal influenza, also referred to as influenza or flu, is a contagious respiratory viral illness. Influenza infection varies in severity, causing asymptomatic infection to fatal disease, particularly for high-risk patient populations such as the elderly (over 65 years of age), young children (under five years of age), pregnant women,...
Published: 10/28/2024
|
Inventor(s):
James Kobie
,
Luis Martinez-Sobrido
,
Michael Piepenbrink
,
Aitor Nogales-Gonzalez
Keywords(s):
Category(s):
Therapeutic
Human Monoclonal Antibodies for Prevention and Treatment of Influenza Virus Infections
Background Seasonal influenza, also referred to as influenza or flu, is a contagious respiratory viral illness. Influenza infection varies in severity, causing asymptomatic infection to fatal disease, particularly for high-risk patient populations such as the elderly (over 65 years of age), young children (under five years of age), pregnant women,...
Published: 10/28/2024
|
Inventor(s):
James Kobie
,
Luis Martinez-Sobrido
,
Aitor Nogales-Gonzalez
,
Michael Piepenbrink
Keywords(s):
Category(s):
Therapeutic
Glucuronoxylomannan (GXM) for Use in Drug Delivery to Central Nervous System
Polysaccharide Related to the Cause of Fungal Meningitis Temporarily Breaks Down Blood-Brain Barrier, Suggesting Effective Delivery of Therapeutics This major capsular polysaccharide of the fungus Cryptococcus neoformans (C. neoformans), glucuronoxylomannan (GXM), can be administered with or attached to a drug to temporarily enable it to cross the...
Published: 2/22/2024
|
Inventor(s):
Luis Martinez
Keywords(s):
Category(s):
Technology Classifications > Human Health Care > Drug Delivery
,
Technology Classifications > Human Health Care > Others
Reorganization of Arenavirus Genome for Development of Novel Arenavirus Live-Attenuated Vaccines (LAV)
Disclosed are compositions and methods related to recombinant arenaviruses and their use in vaccines for the treatment or prevention of an arenavirus infection.
Published: 10/28/2024
|
Inventor(s):
Juan Carlos De La Torre
,
Luis Martinez-Sobrido
,
Masaharu Iwasaki
,
Beatrice Cubitt
Keywords(s):
Category(s):
Vaccines
Network-Coded Multiple Access
[Licensing negotiation in progress] [Invitation for Expression of Interest - Deadline: 16 June 2016] Systems and methods include a first wireless local area network (WLAN) system that jointly exploit physical-layer network coding (PNC) and multi-user decoding (MUD) to boost system throughput. This multiple access mode is referred to as Network-Coded...
Published: 1/29/2024
|
Inventor(s):
Soung Chang Liew
,
Lu LU
,
Lizhao You
Keywords(s):
Network Coding
,
Wireless Local Area Network
Category(s):
Information and Communications Technology
Development of Arenavirus Vaccines through Codon Deoptimization
A novel strategy for developing live-attenuated arenavirus vaccines. Problem Solved by the TechnologyArenaviruses have a significant impact on public health and pose a credible threat to biodefense.There are four arenaviruses that cause severe hemorrhagic fever in humans (Lassa virus, endemic to Africa; and Machupo, Junin, and Guanarito viruses endemic...
Published: 10/28/2024
|
Inventor(s):
Luis Martinez-Sobrido
,
Juan Carlos De La Torre
Keywords(s):
Category(s):
Vaccines